Загрузка...
Oral Disease-Modifying Therapies for Multiple Sclerosis
Classical multiple sclerosis (MS) treatments using first-line injectable drugs, although widely applied, remain a major concern in terms of therapeutic adherence and efficacy. New oral drugs recently approved for MS treatment represent significant advances in therapy. The oral route of administratio...
Сохранить в:
| Опубликовано в: : | J Clin Neurol |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Korean Neurological Association
2015
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4302185/ https://ncbi.nlm.nih.gov/pubmed/25628732 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3988/jcn.2015.11.1.9 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|